Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Contemporary Biological Insights and Clinical Management of Craniopharyngioma
John Apps, Hermann L. Müller, Todd C. Hankinson, et al.
Endocrine Reviews (2022) Vol. 44, Iss. 3, pp. 518-538
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage
Julia Beckhaus, Carsten Friedrich, Svenja Boekhoff, et al.
European Journal of Endocrinology (2023) Vol. 188, Iss. 3, pp. 300-309
Closed Access | Times Cited: 21
Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis
Eric Prince, John Apps, John Jeang, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 6, pp. 1109-1123
Closed Access | Times Cited: 7
Long-term weight gain in children with craniopharyngioma
Sibylle Rovani, Victoria Butler, Dinane Samara‐Boustani, et al.
European Journal of Endocrinology (2024) Vol. 190, Iss. 5, pp. 363-373
Open Access | Times Cited: 7
Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma
Ying Guo, Lili Pei, Yuzheng Li, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 14
Outcome after proton beam therapy versus photon-based radiation therapy in childhood-onset craniopharyngioma patients—results of KRANIOPHARYNGEOM 2007
Carsten Friedrich, Svenja Boekhoff, Martin Bischoff, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunities
Kailash Ahirwar, Ankit Kumar, Nidhi Srivastava, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 131048-131048
Closed Access | Times Cited: 4
Axl as a potential therapeutic target for adamantinomatous craniopharyngiomas: Based on single nucleus RNA-seq and spatial transcriptome profiling
Yiguang Chen, Xiaohai Liu, Yilamujiang Ainiwan, et al.
Cancer Letters (2024) Vol. 592, pp. 216905-216905
Closed Access | Times Cited: 4
New drugs in pituitary diseases
Fernando Cordido, Pedro Iglesias
Endocrinología Diabetes y Nutrición (2025), pp. 501546-501546
Closed Access
Current clinical trials for craniopharyngiomas: what’s on the horizon?
Nikhil Joshi, Sabine Mueller, Cassie Kline
Journal of Neuro-Oncology (2025)
Open Access
The spectrum of radiation therapy options for craniopharyngioma: a systematic review
Paul M. Harary, Sanjeeth Rajaram, Yusuke Hori, et al.
Journal of Neuro-Oncology (2025)
Closed Access
New drugs in pituitary diseases
Fernando Cordido, Pedro Iglesias
Endocrinología Diabetes y Nutrición (English ed ) (2025) Vol. 72, Iss. 3, pp. 501546-501546
Closed Access
Long-term quality of life and hypothalamic dysfunction after craniopharyngioma
Hermann L. Müller
Journal of Neuro-Oncology (2025)
Closed Access
Daytime sleepiness and health-related quality of life in patients with childhood-onset craniopharyngioma
Laura Verena Mann-Markutzyk, Julia Beckhaus, Jale Özyurt, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Metabolic complications and their mechanisms in patients with craniopharyngioma
Eva Marie Erfurth, Hermann L. Müller
Best Practice & Research Clinical Endocrinology & Metabolism (2025), pp. 101999-101999
Closed Access
Growth hormone replacement therapy in childhood-onset craniopharyngioma
Laura van Iersel, Jiska van Schaïk, Hanneke M. van Santen
Best Practice & Research Clinical Endocrinology & Metabolism (2025), pp. 101998-101998
Open Access
Prognostic Impact of Hypothalamic Perforation in Adult Patients With Craniopharyngioma: A Cohort Study
S. Gaillard, Sandro Benichi, Chiara Villa, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 8, pp. 2083-2096
Open Access | Times Cited: 3
Impact of parental body mass index at diagnosis on obesity in survivors of pediatric craniopharyngioma
Julia Beckhaus, Maria Eveslage, Brigitte Bison, et al.
Endocrine Connections (2024) Vol. 13, Iss. 8
Open Access | Times Cited: 3
Adamantinomatous craniopharyngioma: evolution in the management
Luca Massimi, Davide Palombi, Alessandra Musarra, et al.
Child s Nervous System (2023) Vol. 39, Iss. 10, pp. 2613-2632
Open Access | Times Cited: 7
Vision-related quality of life in patients with childhood-onset craniopharyngioma
Panjarat Sowithayasakul, Julia Beckhaus, Svenja Boekhoff, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Tocilizumab for the fifth progression of cystic childhood craniopharyngioma—a case report
Evelien de Vos‐Kerkhof, Dennis R. Buis, Maarten H. Lequin, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Recurrent adamantinomatous craniopharyngiomas show MAPK pathway activation, clonal evolution and rare TP53-loss-mediated malignant progression
John Apps, José Mario González-Meljem, Romain Guiho, et al.
Acta Neuropathologica Communications (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 2
Craniopharyngiomas and proton beam therapy: worth the expense?
Ashley Grossman, Michael Kosmin
The Lancet Oncology (2023) Vol. 24, Iss. 5, pp. 422-423
Closed Access | Times Cited: 4
An update on multimodal management of craniopharyngioma in children
Laura‐Nanna Lohkamp, Ekkehard M. Kasper, Alexandra Espinosa Pousa, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Perinatally diagnosed congenital craniopharyngiomas in the KRANIOPHARYNGEOM trials
Julia Beckhaus, Svenja Boekhoff, Katrin Scheinemann, et al.
Endocrine Connections (2023) Vol. 12, Iss. 12
Open Access | Times Cited: 4
Advances in the treatment of Adamantinomatous craniopharyngioma: How to balance tumor control and quality of life in the current environment: a narrative review
Ao Chen, Mingda Ai, Tao Sun
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top